MERREM I.V. is Active Against Gram-Positives

§

MERREM I.V. offers in vitro activity against certain gram-positive aerobic and anaerobic microorganisms. 1

100%
Methicillin-susceptible Staphylococcus aureus (MSSA) 6//
(n=326) β-lactamase- and non- β-lactamase-producing, methicillin-susceptible isolates only.

98.9%
Streptococcus agalactiae (Group B) 8¶
(n=91)

97.9%
Streptococcus pyogenes (Group A) 8#
(n=47)

92.5%
Viridans group streptococci 8¶
(n=40)

90.4%
Streptococcus pneumoniae 8#
(n=83)

75.3%
Enterococcus faecalis 8#
(n=97) Excluding vancomycin-resistant isolates.

§(n = number of isolates)
//Data from US MYSTIC database 2005 provided by AstraZeneca
¶ Data from North American MYSTIC database 2003 provided by AstraZeneca
# Data from North American MYSTIC database 2005 provided by AstraZeneca

MERREM I.V. Has Demonstrated In Vitro Activity Against The Following Gram-Positive Microorganisms, But The Clinical Significance Of These Data Is Unknown 1

Aerobic and Facultative Gram-Positive Microorganisms 1

Staphylococcus epidermidis (β-lactamase producing, MSSA only)
Staphylococcus epidermidis (Non-β-lactamase producing, MSSA only)

In vitro activity does not necessarily correlate with clinical effectiveness.

Next Page > Anaerobes